Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates and calculations
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 COVID-19 impact analysis at global level
1.7 Data sources
1.7.1 Secondary
1.7.1.1 Paid sources
1.7.1.2 Unpaid sources
1.7.2 Primary
Chapter 2 Executive Summary
2.1 Preterm birth diagnostic test kits market industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product type trends
2.1.4 Sample type trends
2.1.5 End-use trends
Chapter 3 Preterm Birth Diagnostic Test Kits Industry Insights
3.1 Industry segmentation
3.2 Industry ecosystem analysis
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Growing incidence of preterm births
3.3.1.2 Increasing awareness of preterm births and their complications
3.3.1.3 Surge in number of pediatric and neonatal intensive care units
3.3.1.4 Rising development of new and improved diagnostic test kits
3.3.2 Industry pitfalls & challenges
3.3.2.1 Lack of awareness regarding these kits
3.3.2.2 High cost of kits
3.4 Growth potential analysis
3.4.1 By product type
3.4.2 By sample type
3.4.3 By end-use
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive landscape
4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Competitive dashboard
4.4 Company market share, 2021
4.5 Competitive analysis of major market players
4.6 Competitive positioning matrix
4.7 Strategic outlook matrix
Chapter 5 Preterm Birth Diagnostic Test Kits Market and Forecast, By Product Type (USD Million)
5.1 Key trends, by product type
5.2 Fetal fibronectin test kits (fFN)
5.3 Placental alpha micro-globulin-1 test kits (PAMG-1)
5.4 Insulin like growth factor binding protein-1 test kits (IGFBP-1)
5.5 Others
Chapter 6 Preterm Birth Diagnostic Test Kits Market and Forecast, By Sample type (USD Million)
6.1 Key trends, by sample type
6.2 Blood sample
6.3 Urine sample
6.4 Vaginal discharge sample
Chapter 7 Preterm Birth Diagnostic Test Kits Market and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Diagnostic centers
7.4 Clinics
7.5 Others
Chapter 8 Preterm Birth Diagnostic Test Kits Market and Forecast, By Region (USD Million)
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Russia
8.3.7 Poland
8.3.8 Switzerland
8.3.9 Norway
8.3.10 Finland
8.3.11 Sweden
8.3.12 Denmark
8.3.13 The Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Vietnam
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Creative Diagnostics
9.3 Clinical Innovations
9.4 Hologic
9.5 IQ Products
9.6 Qiagen
9.7 Medixbiochemica
9.8 Biosynex
9.9 CooperSurgical Inc
9.10 Sera Progonstics
9.11 Stryker Corporation
